Navitas stock soars as company advances 800V tech for NVIDIA AI platforms
Investing.com -- Sanofi (NASDAQ:SNY) has started shipping its flu vaccine portfolio for the 2025-2026 season to health facilities across the United States, the company announced today.
The vaccine distribution comes after a severe 2024-2025 flu season that resulted in 130,000 deaths in the U.S.
Thomas Grenier, Head of North America, Vaccines at Sanofi, shared his personal experience with the flu: "The past year’s flu season was undoubtedly one of the worst in decades. It even hit me (and members of my family twice, first with influenza A and then influenza B)! I relocated my workstation to bed for a few days."
Sanofi’s vaccines are being delivered to health systems, hospitals, pharmacies, physician practices, nursing homes, and other facilities throughout the country. The company describes itself as "all-in on a relentless effort to ensure every eligible person in the U.S. has access to a flu vaccine."
The Centers for Disease Control and Prevention (CDC) recommends September and October as generally good times for most people to get vaccinated against the flu, particularly for those who need only one dose of influenza vaccine for the season.
As a major player in immunization globally, Sanofi aims to reduce both the risk of infection and severe consequences through its portfolio of flu vaccines for eligible patients.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.